AGIO vs EVRG · rev $65.5M vs P/E 22, rev $5.96B
Agios Pharm (AGIO) versus Evergy, Inc. (EVRG) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported EVRG revenue for 2025-12-31 was $5.96B. Net income was $855.6M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
AGIO currently screens at market cap $1.68B. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Not investment advice. Open the AGIO and EVRG stock pages for the full models.
Not investment advice.